Abstract
Another big drug firm is joining the mRNA therapy field. Pfizer is paying BioNTech $120 million to develop mRNA flu vaccines and offering up to $305 million more in potential milestone payments. Mo...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have